Extremely membrane-permeant precursor of the specific PKA agonist 6-Bnz-cAMP (Cat. No. B009). After permeation and metabolic activation by esterases the active compound ist released. 6-Bnz-cAMP-AM does not activate Epac and thus can be used as an Epac-negative control. Reference: Leech et al., Islets, 2, 72 - 81 (2010).
Control reagent for nucleotide AM-ester applications: PO4-AM3, Cat. No. P 030
Cat. No. | B 079 |
CAS number | [pending] |
Purity | > 97 % HPLC for mixture of isomers |
Storage temperature | -20°C / -4°F |
Molecular formula | C₂₀H₂₀N₅O₉P |
Molecular weight [g/mol] | 505.4 |
Target | PKA (cAK) Activator |
Absorption max [nm] | 279 |
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] | 17000 |